The Marcus Corporation Reports Third Quarter Fiscal 2022 Results
The Marcus Corporation (NYSE: MCS) reported strong third-quarter results for fiscal 2022, with revenues reaching $183.7 million, a 25.9% increase from the previous year. Operating income improved to $8.9 million, while net earnings rose to $3.3 million, or $0.10 per diluted share. The hotel division exceeded pre-pandemic revenue levels, and the theatres segment saw a 28% increase in attendance despite a lackluster film slate. A quarterly cash dividend of $0.05 per share was also announced, highlighting the company's financial resilience.
- Total revenues increased by 25.9% to $183.7 million in Q3 2022.
- Operating income rose to $8.9 million, up from $6.3 million year-over-year.
- Net earnings improved to $3.3 million, or $0.10 per diluted share.
- The hotel division exceeded pre-pandemic revenue levels by 9%.
- Marcus Theatres reported a 28% increase in attendance compared to the prior year.
- Marcus Theatres was impacted by a lighter film slate during the quarter.
“Our results during the third quarter of fiscal 2022 were a significant improvement compared to the prior year period with both divisions again outperforming their respective industries and generating positive cash flow from operations,” said
Third Quarter Fiscal 2022 Highlights
-
Total revenues for the third quarter of fiscal 2022 were
, a$183.7 million 25.9% increase from total revenues of for the third quarter of fiscal 2021.$145.9 million
-
Operating income was
for the third quarter of fiscal 2022, compared to operating income of$8.9 million for the prior year quarter.$6.3 million
-
Net earnings attributable to
The Marcus Corporation was for the third quarter of fiscal 2022, compared to net earnings attributable to$3.3 million The Marcus Corporation of for the same period in fiscal 2021.$1.8 million
-
Net earnings per diluted common share attributable to
The Marcus Corporation was for the third quarter of fiscal 2022, compared to net earnings per diluted common share attributable to$0.10 The Marcus Corporation of for the third quarter of fiscal 2021.$0.06
-
Adjusted EBITDA was
for the third quarter of fiscal 2022, compared to Adjusted EBITDA of$27.9 million for the prior year quarter.$24.5 million
-
On
November 2, 2022 , the Board of Directors ofThe Marcus Corporation declared a regular quarter cash dividend of per share of common stock, to be paid$0.05 December 15, 2022 , to shareholders of record onNovember 25, 2022 . The Board of Directors also declared a dividend of per share of Class B common stock, to be paid$0.04 5December 15, 2022 , to shareholders of record as ofNovember 25, 2022 .
First Three Quarters Fiscal 2022 Highlights
-
Total revenues for the first three quarters of fiscal 2022 were
, a$514.4 million 77.9% increase from total revenues of for the first three quarters of fiscal 2021.$289.2 million
-
Operating income was
for the first three quarters of fiscal 2022, compared to operating loss of$11.0 million for the first three quarters of fiscal 2021.$55.5 million
-
Net loss attributable to
The Marcus Corporation was for the first three quarters of fiscal 2022, compared to net loss attributable to$2.7 million The Marcus Corporation of for the same period in fiscal 2021.$49.7 million
-
Net loss per diluted common share attributable to
The Marcus Corporation was for the first three quarters of fiscal 2022, compared to net loss per diluted common share attributable to$0.09 The Marcus Corporation of for the first three quarters of fiscal 2021.$1.66
-
Adjusted EBITDA was
for the first three quarters of fiscal 2022, compared to Adjusted EBITDA of$68.5 million for the first three quarters of fiscal 2021.$5.8 million
Adjusted EBITDA reflects an adjustment made by the company to eliminate the impact of noncash impairment charges and the favorable impact of a nonrecurring state government grant during the first three quarters of fiscal 2021.
Revenue per available room (RevPAR) increased at seven of eight company-owned properties during the third quarter of fiscal 2022 compared to the prior year quarter and increased at all company-owned properties during the first three quarters of fiscal 2022 compared to the same period in 2021. The division again outperformed both the industry and its competitive sets during the third quarter of fiscal 2022 by 1.8 and 1.4 percentage points, respectively.
“Overall hotel occupancy has reached its highest level since the start of the pandemic, with division revenue exceeding the same pre-pandemic period in 2019 by 9 percent,” said
The leisure travel market remains strong, particularly on the weekends, with customers combining business trips with extended weekend leisure stays. Group and business travel continues to increase as more employees return to the office and organizations host more training events, meetings and conferences. Although group business remains behind prior years, group booking pace increased during the third quarter of fiscal 2022 to 95 percent of pre-pandemic third quarter fiscal 2019 booking pace. Increases in corporate group, social event and wedding bookings also helped drive increased food and beverage revenue in the quarter.
In October, seven
Revenue for
For the fifth straight quarter,
“Yet again, each of the top five performing films in the quarter opened with an exclusive theatrical run, continuing to demonstrate the importance of theatres in driving excitement and sales for films of all types,” said
Marcus Theatres’ top five highest-performing films in the third quarter of fiscal 2022 were Minions: The Rise of Gru, Thor: Love and Thunder, Top Gun: Maverick, Where the Crawdads Sing and Nope. Each of these films debuted with an exclusive theatrical window. Several films have performed well early in the fourth quarter of fiscal 2022, including Black Adam, Smile and
Balance Sheet and Liquidity
The Marcus Corporation’s financial position remains strong with
Diluted weighted average shares outstanding and diluted net earnings per common share include the dilutive effect of conversion of the Company’s convertible notes to the extent conversion is dilutive in each period. During the third quarter of fiscal 2022, diluted weighted average shares outstanding includes 9.1 million shares from the dilutive effect of the convertible notes, which were excluded from diluted weighted average shares outstanding in the other periods presented as the convertible notes were antidilutive. Diluted weighted average shares outstanding does not include the benefit from the capped call transactions the Company entered into in connection with the issuance of the convertible notes, which mitigate the dilutive effect of the convertible notes by approximately 2.9 million shares during the third quarter of fiscal 2022. Upon conversion, the convertible notes may be settled, at the Company’s election, in cash, shares of common stock or a combination thereof.
Conference Call and Webcast
A telephone replay of the conference call will be available through
Non-GAAP Financial Measure
Adjusted EBITDA has been presented in this press release as a supplemental measure of financial performance that is not required by, or presented in accordance with, GAAP. The company defines Adjusted EBITDA as net earnings (loss) attributable to
Adjusted EBITDA is a key measure used by management and the company’s board of directors to assess the company’s financial performance and enterprise value. The company believes that Adjusted EBITDA is a useful measure, as it eliminates certain expenses and gains that are not indicative of the company’s core operating performance and facilitates a comparison of the company’s core operating performance on a consistent basis from period to period. The company also uses Adjusted EBITDA as a basis to determine certain annual cash bonuses and long-term incentive awards, to supplement GAAP measures of performance to evaluate the effectiveness of its business strategies, to make budgeting decisions, and to compare its performance against that of other peer companies using similar measures. Adjusted EBITDA is also used by analysts, investors and other interested parties as a performance measure to evaluate industry competitors.
Adjusted EBITDA is a non-GAAP measure of the company’s financial performance and should not be considered as an alternative to net earnings (loss) as a measure of financial performance, or any other performance measure derived in accordance with GAAP and it should not be construed as an inference that the company’s future results will be unaffected by unusual or non-recurring items. Additionally, Adjusted EBITDA is not intended to be a measure of liquidity or free cash flow for management’s discretionary use. In addition, this non-GAAP measure excludes certain non-recurring and other charges and has its limitations as an analytical tool. You should not consider Adjusted EBITDA in isolation or as a substitute for analysis of the company’s results as reported under GAAP. In evaluating Adjusted EBITDA, you should be aware that in the future the company will incur expenses that are the same as or similar to some of the items eliminated in the adjustments made to determine Adjusted EBITDA, such as acquisition expenses, preopening expenses, accelerated depreciation, impairment charges and other adjustments. The company’s presentation of Adjusted EBITDA should not be construed to imply that the company’s future results will be unaffected by any such adjustments. Definitions and calculations of Adjusted EBITDA differ among companies in our industries, and therefore Adjusted EBITDA disclosed by the company may not be comparable to the measures disclosed by other companies.
About
Headquartered in
Certain matters discussed in this press release are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements may generally be identified as such because the context of such statements include words such as we “believe,” “anticipate,” “expect” or words of similar import. Similarly, statements that describe our future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties which may cause results to differ materially from those expected, including, but not limited to, the following: (1) the adverse effects of the COVID-19 pandemic on our theatre and hotels and resorts businesses, results of operations, liquidity, cash flows, financial condition, access to credit markets and ability to service our existing and future indebtedness; (2) the duration of the COVID-19 pandemic and related government restrictions and the level of customer demand following the relaxation of such requirements; (3) the availability, in terms of both quantity and audience appeal, of certain motion pictures for our theatre division (particularly following the COVID-19 pandemic, during which the release dates for motion pictures have been postponed), as well as other industry dynamics such as the maintenance of a suitable window between the date such motion pictures are released in theatres and the date they are released to other distribution channels; (4) the effects of adverse economic conditions in our markets, including but not limited to, those caused by the COVID-19 pandemic; (5) the effects of adverse economic conditions, including but not limited to, those caused by the COVID-19 pandemic, on our ability to obtain financing on reasonable and acceptable terms, if at all; (6) the effects on our occupancy and room rates caused by the COVID-19 pandemic and the effects on our occupancy and room rates caused by the relative industry supply of available rooms at comparable lodging facilities in our markets; (7) the effects of competitive conditions in our markets; (8) our ability to achieve expected benefits and performance from our strategic initiatives and acquisitions; (9) the effects of increasing depreciation expenses, reduced operating profits during major property renovations, impairment losses, and preopening and start-up costs due to the capital intensive nature of our business; (10) the effects of changes in the availability of and cost of labor and other supplies essential to the operation of our business; (11) the effects of weather conditions, particularly during the winter in the Midwest and in our other markets; (12) our ability to identify properties to acquire, develop and/or manage and the continuing availability of funds for such development; (13) the adverse impact on business and consumer spending on travel, leisure and entertainment resulting from terrorist attacks in
Consolidated Statements of Earnings (Loss) (Unaudited) (in thousands, except per share data) |
|||||||||||||||
|
13 Weeks Ended |
|
39 Weeks Ended |
||||||||||||
|
|
|
|
|
|
|
|
||||||||
Revenues: |
|
|
|
|
|
|
|
||||||||
Theatre admissions |
$ |
49,424 |
|
|
$ |
38,250 |
|
|
$ |
150,928 |
|
|
$ |
73,850 |
|
Rooms |
|
36,924 |
|
|
|
30,917 |
|
|
|
83,219 |
|
|
|
57,293 |
|
Theatre concessions |
|
44,715 |
|
|
|
35,952 |
|
|
|
138,326 |
|
|
|
68,932 |
|
Food and beverage |
|
21,444 |
|
|
|
16,731 |
|
|
|
54,969 |
|
|
|
32,234 |
|
Other revenues |
|
22,174 |
|
|
|
19,128 |
|
|
|
62,173 |
|
|
|
45,253 |
|
|
|
174,681 |
|
|
|
140,978 |
|
|
|
489,615 |
|
|
|
277,562 |
|
Cost reimbursements |
|
8,969 |
|
|
|
4,884 |
|
|
|
24,832 |
|
|
|
11,634 |
|
Total revenues |
|
183,650 |
|
|
|
145,862 |
|
|
|
514,447 |
|
|
|
289,196 |
|
|
|
|
|
|
|
|
|
||||||||
Costs and expenses: |
|
|
|
|
|
|
|
||||||||
Theatre operations |
|
54,756 |
|
|
|
40,513 |
|
|
|
160,921 |
|
|
|
87,660 |
|
Rooms |
|
11,856 |
|
|
|
9,682 |
|
|
|
30,530 |
|
|
|
22,019 |
|
Theatre concessions |
|
17,868 |
|
|
|
15,094 |
|
|
|
56,054 |
|
|
|
29,627 |
|
Food and beverage |
|
16,150 |
|
|
|
12,344 |
|
|
|
43,325 |
|
|
|
25,520 |
|
Advertising and marketing |
|
6,544 |
|
|
|
4,827 |
|
|
|
17,003 |
|
|
|
11,195 |
|
Administrative |
|
19,995 |
|
|
|
16,536 |
|
|
|
56,703 |
|
|
|
45,815 |
|
Depreciation and amortization |
|
16,452 |
|
|
|
17,730 |
|
|
|
50,435 |
|
|
|
54,203 |
|
Rent |
|
6,672 |
|
|
|
6,544 |
|
|
|
19,500 |
|
|
|
19,229 |
|
Property taxes |
|
4,911 |
|
|
|
4,935 |
|
|
|
14,636 |
|
|
|
14,142 |
|
Other operating expenses |
|
10,528 |
|
|
|
6,500 |
|
|
|
29,463 |
|
|
|
19,918 |
|
Impairment charges |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,732 |
|
Reimbursed costs |
|
8,969 |
|
|
|
4,884 |
|
|
|
24,832 |
|
|
|
11,634 |
|
Total costs and expenses |
|
174,701 |
|
|
|
139,589 |
|
|
|
503,402 |
|
|
|
344,694 |
|
|
|
|
|
|
|
|
|
||||||||
Operating income (loss) |
|
8,949 |
|
|
|
6,273 |
|
|
|
11,045 |
|
|
|
(55,498 |
) |
|
|
|
|
|
|
|
|
||||||||
Other income (expense): |
|
|
|
|
|
|
|
||||||||
Investment income (loss) |
|
(35 |
) |
|
|
(7 |
) |
|
|
(762 |
) |
|
|
153 |
|
Interest expense |
|
(3,688 |
) |
|
|
(4,600 |
) |
|
|
(11,843 |
) |
|
|
(14,350 |
) |
Other income (expense) |
|
(384 |
) |
|
|
(625 |
) |
|
|
(1,545 |
) |
|
|
(1,881 |
) |
Gain (loss) on disposition of property, equipment and other assets |
|
(88 |
) |
|
|
868 |
|
|
|
267 |
|
|
|
2,908 |
|
Equity earnings (losses) from unconsolidated joint ventures |
|
30 |
|
|
|
— |
|
|
|
(104 |
) |
|
|
— |
|
|
|
(4,165 |
) |
|
|
(4,364 |
) |
|
|
(13,987 |
) |
|
|
(13,170 |
) |
|
|
|
|
|
|
|
|
||||||||
Earnings (loss) before income taxes |
|
4,784 |
|
|
|
1,909 |
|
|
|
(2,942 |
) |
|
|
(68,668 |
) |
Income tax expense (benefit) |
|
1,495 |
|
|
|
150 |
|
|
|
(289 |
) |
|
|
(18,931 |
) |
Net earnings (loss) |
|
3,289 |
|
|
|
1,759 |
|
|
|
(2,653 |
) |
|
|
(49,737 |
) |
Net earnings (loss) attributable to noncontrolling interests |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Net earnings (loss) attributable to |
$ |
3,289 |
|
|
$ |
1,759 |
|
|
$ |
(2,653 |
) |
|
$ |
(49,737 |
) |
|
|
|
|
|
|
|
|
||||||||
Net earnings (loss) per common share attributable to |
|
|
|
|
|
|
|
||||||||
|
$ |
0.10 |
|
|
$ |
0.06 |
|
|
$ |
(0.09 |
) |
|
$ |
(1.66 |
) |
|
|
|
|
|
|
|
|
||||||||
Weighted average shares outstanding - diluted |
|
40,702 |
|
|
|
31,469 |
|
|
|
31,481 |
|
|
|
31,340 |
|
Condensed Consolidated Balance Sheets (In thousands) |
|||||
|
(Unaudited) |
|
(Audited) |
||
|
|
|
|
||
|
|
|
|
||
Assets: |
|
|
|
||
|
|
|
|
||
Cash and cash equivalents |
$ |
10,529 |
|
$ |
17,658 |
Restricted cash |
|
6,266 |
|
|
6,396 |
Accounts receivable |
|
26,127 |
|
|
28,902 |
Government grants receivable |
|
— |
|
|
4,335 |
Refundable income taxes |
|
— |
|
|
22,435 |
Assets held for sale |
|
517 |
|
|
4,856 |
Other current assets |
|
17,992 |
|
|
15,364 |
Property and equipment, net |
|
748,796 |
|
|
771,192 |
Operating lease right-of-use assets |
|
205,414 |
|
|
217,072 |
Other assets |
|
100,583 |
|
|
100,151 |
|
|
|
|
||
Total Assets |
$ |
1,116,224 |
|
$ |
1,188,361 |
|
|
|
|
||
Liabilities and Shareholders' Equity: |
|
|
|
||
|
|
|
|
||
Accounts payable |
$ |
24,609 |
|
$ |
35,781 |
Taxes other than income taxes |
|
18,344 |
|
|
19,566 |
Other current liabilities |
|
71,127 |
|
|
80,152 |
Short-term borrowings |
|
— |
|
|
47,346 |
Current portion of finance lease obligations |
|
2,485 |
|
|
2,561 |
Current portion of operating lease obligations |
|
15,930 |
|
|
16,795 |
Current maturities of long-term debt |
|
11,095 |
|
|
10,967 |
Finance lease obligations |
|
15,528 |
|
|
17,192 |
Operating lease obligations |
|
203,675 |
|
|
216,064 |
Long-term debt |
|
212,530 |
|
|
204,177 |
Deferred income taxes |
|
26,406 |
|
|
26,183 |
Other long-term obligations |
|
57,267 |
|
|
57,963 |
Equity |
|
457,228 |
|
|
453,614 |
|
|
|
|
||
Total Liabilities and Shareholders' Equity |
$ |
1,116,224 |
|
$ |
1,188,361 |
Business Segment Information (Unaudited) (In thousands) |
||||||||||||||
|
Theatres |
|
Hotels/
|
|
Corporate
|
|
Total |
|||||||
13 Weeks Ended |
|
|
|
|
|
|
|
|||||||
Revenues |
$ |
101,258 |
|
|
$ |
82,300 |
|
$ |
92 |
|
|
$ |
183,650 |
|
Operating income (loss) |
|
(723 |
) |
|
|
14,120 |
|
|
(4,448 |
) |
|
|
8,949 |
|
Depreciation and amortization |
|
11,632 |
|
|
|
4,733 |
|
|
87 |
|
|
|
16,452 |
|
Adjusted EBITDA |
|
12,454 |
|
|
|
19,065 |
|
|
(3,654 |
) |
|
|
27,865 |
|
|
|
|
|
|
|
|
|
|||||||
13 Weeks Ended |
|
|
|
|
|
|
|
|||||||
Revenues |
$ |
79,996 |
|
|
$ |
65,803 |
|
$ |
63 |
|
|
$ |
145,862 |
|
Operating income (loss) |
|
(2,604 |
) |
|
|
13,458 |
|
|
(4,581 |
) |
|
|
6,273 |
|
Depreciation and amortization |
|
12,636 |
|
|
|
5,018 |
|
|
76 |
|
|
|
17,730 |
|
Adjusted EBITDA |
|
10,605 |
|
|
|
16,988 |
|
|
(3,078 |
) |
|
|
24,515 |
|
|
|
|
|
|
|
|
|
|||||||
39 Weeks Ended |
|
|
|
|
|
|
|
|||||||
Revenues |
$ |
310,186 |
|
|
$ |
203,958 |
|
$ |
303 |
|
|
$ |
514,447 |
|
Operating income (loss) |
|
7,687 |
|
|
|
17,963 |
|
|
(14,605 |
) |
|
|
11,045 |
|
Depreciation and amortization |
|
35,686 |
|
|
|
14,484 |
|
|
265 |
|
|
|
50,435 |
|
Adjusted EBITDA |
|
45,986 |
|
|
|
33,282 |
|
|
(10,752 |
) |
|
|
68,516 |
|
|
|
|
|
|
|
|
|
|||||||
39 Weeks Ended |
|
|
|
|
|
|
|
|||||||
Revenues |
$ |
154,859 |
|
|
$ |
134,079 |
|
$ |
258 |
|
|
$ |
289,196 |
|
Operating income (loss) |
|
(46,458 |
) |
|
|
5,511 |
|
|
(14,551 |
) |
|
|
(55,498 |
) |
Depreciation and amortization |
|
38,807 |
|
|
|
15,192 |
|
|
204 |
|
|
|
54,203 |
|
Adjusted EBITDA |
|
(3,566 |
) |
|
|
20,026 |
|
|
(10,630 |
) |
|
|
5,830 |
|
Corporate items include amounts not allocable to the business segments. Corporate revenues consist principally of rent and the corporate operating loss includes general corporate expenses. Corporate information technology costs and accounting shared services costs are allocated to the business segments based upon several factors, including actual usage and segment revenues. |
Supplemental Data (Unaudited) (In thousands) |
||||||||||||||||
|
|
13 Weeks Ended |
|
39 Weeks Ended |
||||||||||||
Consolidated |
|
|
|
|
|
|
|
|
||||||||
Net cash flow provided by (used in) operating activities |
|
$ |
5,134 |
|
|
$ |
11,738 |
|
|
$ |
60,362 |
|
|
$ |
2,057 |
|
Net cash flow provided by (used in) investing activities |
|
|
(11,388 |
) |
|
|
12,993 |
|
|
|
(22,863 |
) |
|
|
9,248 |
|
Net cash flow provided by (used in) financing activities |
|
|
(40,369 |
) |
|
|
(24,886 |
) |
|
|
(44,758 |
) |
|
|
(10,418 |
) |
Capital expenditures |
|
|
(11,142 |
) |
|
|
(2,926 |
) |
|
|
(27,483 |
) |
|
|
(9,121 |
) |
Reconciliation of Net earnings (loss) to Adjusted EBITDA (Unaudited) (In thousands) |
|||||||||||||||
|
13 Weeks Ended |
|
39 Weeks Ended |
||||||||||||
|
|
|
|
|
|
|
|
||||||||
Net earnings (loss) attributable to |
$ |
3,289 |
|
|
$ |
1,759 |
|
|
$ |
(2,653 |
) |
|
$ |
(49,737 |
) |
Add (deduct): |
|
|
|
|
|
|
|
||||||||
Investment (income) loss |
|
35 |
|
|
|
7 |
|
|
|
762 |
|
|
|
(153 |
) |
Interest expense |
|
3,688 |
|
|
|
4,600 |
|
|
|
11,843 |
|
|
|
14,350 |
|
Other expense (income) |
|
384 |
|
|
|
625 |
|
|
|
1,545 |
|
|
|
1,881 |
|
(Gain) loss on disposition of property, equipment and other assets |
|
88 |
|
|
|
(868 |
) |
|
|
(267 |
) |
|
|
(2,908 |
) |
Equity (earnings) losses from unconsolidated joint ventures |
|
(30 |
) |
|
|
— |
|
|
|
104 |
|
|
|
— |
|
Income tax expense (benefit) |
|
1,495 |
|
|
|
150 |
|
|
|
(289 |
) |
|
|
(18,931 |
) |
Depreciation and amortization |
|
16,452 |
|
|
|
17,730 |
|
|
|
50,435 |
|
|
|
54,203 |
|
Share-based compensation expenses (a) |
|
2,464 |
|
|
|
2,521 |
|
|
|
7,036 |
|
|
|
6,673 |
|
Impairment charges (b) |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,732 |
|
Government grants (c) |
|
— |
|
|
|
(2,009 |
) |
|
|
— |
|
|
|
(3,280 |
) |
Adjusted EBITDA |
$ |
27,865 |
|
|
$ |
24,515 |
|
|
$ |
68,516 |
|
|
$ |
5,830 |
|
(a) |
Non-cash charges related to share-based compensation programs. |
(b) |
Non-cash impairment charges related to surplus theatre real estate. |
(c) |
Reflects a nonrecurring state government grant awarded for COVID-19 pandemic relief. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20221102006161/en/
(414) 905-1036
investors@marcuscorp.com
Source:
FAQ
What were the total revenues for The Marcus Corporation in Q3 2022?
What is the net earnings per share for MCS in the third quarter of fiscal 2022?
How much did the company increase its quarterly dividend for shareholders?
Did Marcus Hotels & Resorts outperform pre-pandemic levels?